共 48 条
- [1] Michael MD(2014)Work disability and productivity loss in patients with inflammatory bowel diseases in Hungary in the era of biologics Eur J Health Econ 15 121-128
- [2] Avitan AK(2016)The impact of inflammatory bowel disease on work productivity: comparison of a real-world sample of patients with Crohn’s disease and ulcerative colitis Value Health 19 A511-523
- [3] Schwartz D(2010)Ulcerative colitis practice guidelines in adults: American college of gastroenterology, practice parameters committee Am J Gastroenterol 105 501-1725
- [4] Greenberg D(2011)Medical progress in ulcerative colitis—review article N Engl J Med 365 1713-707
- [5] Friger M(2010)How do patients with inflammatory bowel disease want their biological therapy administered? BMC Gastroenterol 10 1-1078
- [6] Vardy H(2010)Systematic review: the costs of ulcerative colitis in Western countries Aliment Pharmacol Ther 31 693-12
- [7] Sarid O(2015)Systematic review: the financial burden of surgical complications in patients with ulcerative colitis Aliment Pharmacol Ther 41 1066-1535
- [8] Slonim-Nevo V(2007)Real-life data: a growing need ISPOR Connections 13 8-303
- [9] Odes S(2016)Indirect costs of inflammatory bowel diseases: Crohn’s disease and ulcerative colitis. A systematic review Arch Med Sci 12 295-19
- [10] Kornbluth A(2007)Rising hospitalization rates for inflammatory bowel disease in the United States between 1998 and 2004 Inflamm Bowel Dis 13 1529-456